Summary Women with breast cancer and a family history of breast cancer and some with sporadic breast cancer are deficient in the repair of radiation-induced DNA damage compared with normal donors with no family history of breast cancer. DNA repair was measured indirectly by quantifying chromatid breaks in phytohaemagglutinin (PHA)-stimulated blood lymphocytes after either X-irradiation or UV-C exposure, with or without post treatment with the DNA repair inhibitor, l-fl-D-arabinofuranosylcytosine (ara-C). We have correlated chromatid breaks with unrepaired DNA strand breaks using responses to X-irradiation of cells from xeroderma pigmentosum patients with well-characterised DNA repair defects or responses of repair-deficient mutant Chinese hamster ovary (CHO) cells with or without transfected human DNA repair genes. Deficient DNA repair appears to be a predisposing factor in familial breast cancer and in some sporadic breast cancers.
The DNA of mammalian cells is continually subject to exogenous and endogenous damaging agents. Radiations from the sun or other sources, chemical mutagens in the atmosphere, foods or drugs, as well as normal metabolites such as hydrogen peroxide and its derivative, *OH, can produce DNA lesions. These lesions, if not repaired, can have serious consequences, resulting in infidelity of replication, mutations, neoplastic transformation and even cell death. Cellular repair mechanisms involving multienzymatic steps have evolved to remove these lesions. Monitoring and repair of DNA damage sustained during G2 phase just before mitosis and distribution of chromosomes to daughter cells appears to play an important role in carcinogenesis.
An abnormally high chromatid break frequency in cells entering metaphase 0.5-1.5 h after X-irradiation was observed in fibroblasts or peripheral blood lymphocytes from individuals with any one of 12 cancer-prone genetic disorders (Sanford et al., 1989; 1993; Parshad et al., 1993a) . The findings on many of these have now been confirmed and three more cancer-prone conditions have been found to have the abnormality (De Bauche et al., 1990; Scott et al., 1994) . This abnormality has been interpreted as resulting from an inherent alteration in chromatin structure (Pandita and Hittelman, 1995) , a higher rate of conversion of doublestrand breaks to chromatid breaks (Mozdarani and Bryant, 1989) or from deficient DNA repair (Sanford et al., 1989 and Parshad et al., 1983) . Furthermore, Scott et al. (1994) have reported an abnormally high frequency of chromatid breaks after G2 phase X-irradiation in PHA-stimulated lymphocytes from 21 of an unselected series of 50 women with apparently sporadic breast cancer. They suggest that predisposing genes for breast cancer are involved in the processing of DNA damage.
Blood lymphocytes or fibroblasts in culture from normal donors and from individuals with a cancer-prone genetic disorder except A-T had equivalent chromatid break frequency when entering metaphase during the first 0.5 h after X-irradiation (Parshad et al., 1983 (Parshad et al., , 1993b Sanford et al., 1987 Takai et al., 1990) . This result indicates similar initial radiosensitivities, i.e. equivalent amounts of initial damage induced by the X-irradiation. Cells from normal donors entering metaphase during the subsequent hour (0.5 to 1.5 h) showed a precipitous decline in chromatid break frequency, whereas those from cancer-prone donors maintained a high or even an increased frequency level (Parshad et al., 1983 (Parshad et al., , 1993a Sanford et al., 1987 Sanford et al., , 1990 Takai et al., 1990) . This differential response apparently does not result from a more rapid transit of the cancer-prone cells through G2 allowing less time to repair the radiation-induced DNA damage; the percentage of irradiated relative to nonirradiated metaphase cells declined at the same rate in cells from both cancer-prone and normal donors and both showed a complete mitotic block at 2 h after irradiation (Parshad et al., 1983; De Bauche et al., 1990) . The decline in chromatid break frequency characterising cells from normal donors apparently results from efficient repair of the underlying DNA damage induced directly or indirectly by the irradiation. This concept is supported by the fact that addition of the DNA repair inhibitor, 1-/B-D arabinofuranosylcytosine (ara-C), which inhibits the polymerase step in excision repair, can prevent the decline and result in increased chromatid breaks at various intervals within 3 h after Xirradiation (Preston et al., 1992; Sanford et al., 1993; Parshad et al., 1993b) . These results suggest that the X-ray-induced DNA lesions leading to chromatid breaks are repaired during this time period through an excision repair pathway in which the DNA is enzymatically incised to remove damaged sites (Friedburg et al., 1995) . In contrast to cells from normal donors, cells from certain cancer-prone individuals showed little ara-C effect on chromatid break frequency (Preston et al., 1992; Sanford et al., 1993; Parshad et al., 1993b preinvasive breast lesions and from normal donors. The results show that deficient repair of the radiation-induced DNA damage is a predisposing factor in familial breast cancer and in some of its sporadic forms.
Materials and methods
Coded blood samples from the normal control donors and from patients with breast lesions were provided by our collaborators. Whereas the control donors were carefully screened, healthy, non-institutionalised subjects, all patients were participants of an ongoing study (NIH Protocol Number 94C-0056) and were sampled before commencement of therapy. In addition, coded samples of blood from three normal donors and two XP patients were kindly provided by Dr K H Kraemer, NCI; some results on these were published previously (Parshad et al., 1993b) .
Mutant CHO cells 27-1 and UV-61 and their derivatives transfected with human DNA repair genes ERCC3 and ERCC6 using pSV3 gpt as vector have been described (Vermeulen et al., 1994; Troelstra et al., 1993) . In repeated experiments the vector alone did not affect DNA repair in the mutant cells (Weeda et al., 1990; Troelstra et al., 1992) . Cultures of these cells were coded by VAB at Baltimore and sent by mail to Bethesda where experiments were conducted.
Experimental procedures
The procedure for X-irradiating 72 h cultures of PHAstimulated peripheral blood lymphocytes has been described previously . Briefly, we added 3.5 ml of freshly drawn blood to a T-25 flask containing 35 ml of RPMI-1640 with 15% fetal bovine serum (FBS) with 10 U ml-' heparin, 0.1 mg ml-' gentamicin and 1% (v/v) PHA (HA 15, Burroughs-Wellcome, Research Triangle Park, NC, USA). The medium was equilibrated with 10% carbon dioxide in air to adjust the pH and was warmed at 37°C before addition of the blood sample. The culture was incubated upright and inverted every 24 h to resuspend cells. After 72 h incubation, cells were X-irradiated as a concentrated suspension of predetermined cell density in 2 ml of medium in a 15 ml borosilicate centrifuge tube at a dose rate of 0.43 Gy min-', total dose 0.48 Gy. The tube was positioned at an angle of 350 on a T-150 flask containing water at 37°C. The pellet was then resuspended in 9 ml of the medium, incubated for 0.5 h and treated with 0.1 jIg colcemid ml-' for 1 h before processing for chromosome analysis. Some of the cultures received ara-C as indicated (Table I) .
Stock lines of CHO cells were maintained as described for fibroblasts (Parshad et al., 1993a induced DNA damage. In the absence of the transfected genes the ara-C effect was low, -4 and 2 compared with 78 and 98 with transfected genes to restore incision activity (Table II) . (Figure 1) . Cells from the one familial breast cancer patient showing a normal response to X-irradiation (chromatid break frequency <60, Figure 1 ) were exposed to UV-C (12 J) another DNAdamaging agent. (Table III) . XP-A and C cells are known to be defective in incision and removal of cyclobutane pyrimidine dimers in the overall genome (Evans et al., 1993) . XP-A cells are also defective in removal of dimers from an active gene, whereas XP-C cells remove dimers normally from the transcribed strand of an active gene, but the non-transcribed strand is not repaired significantly in these cells (Evans et al., 1993) . Thus, the responses of XP cells to X-irradiation in the chromosomal assay correlate to some extent with their responses to UV-induced damage. The ara-C effects of XP-C and XP-A cells, expressed as 17% and 2.4% of normal respectively, correlate extremely well with levels of repair of UV-induced damage of 10-20% and 1% respectively, (Table  I) , as measured by unscheduled DNA synthesis (UDS) (Robbins et al., 1974; Kraemer et al., 1975 and Petinga et al., 1977) . Furthermore, the ara-C effect in CHO cells with or without human DNA repair genes correlates with the known incision activity of the cells. XP cells, usually resistant to Chromatid breaks per 100 metaphase cells
Discussion
Frequencies of chromatid breaks in blood lymphocytes from 9 of 11 individuals with a family history of breast cancer, six with breast cancer, one with preinvasive breast lesions and two with no cancer, was 2-3 fold higher after G2 phase X- Squires and Johnson, 1988; Hoeijmakers and Bootsma, 1994) . Inhibition of the polymerase step by ara-C results in an accumulation of DNA strand breaks which, if unrepaired, are processed into chromatid breaks manifest at the subsequent metaphase (Natarajan et al., 1980; Preston, 1980) . In the absence of ara-C, the high frequency of chromatid breaks in XP-A and C cells after X-irradiation ( (Parshad et al., 1985; Sanford et al., 1990; Scott et al., 1994) , who are at a 4-fold (range 2-to 7-fold) increase in relative risk of breast cancer (Easton, 1994) . Furthermore, in a family with Li-Fraumeni syndrome, members with diverse cancers including those of breast, brain and other soft tissue showed a similar response to X-ray-induced DNA damage (Parshad et al., 1993a) . One affected individual in this family was clinically normal at the time of biopsy to initiate the cell line studied, but developed two primary breast cancers later. Members of this particular family also carry a p53 germline mutation (Srivastava et al., 1990) . Mutated p53 has been associated with breast and other cancers (Buller et al., 1993; Eyfj6rd et al., 1995) , moreover, it has recently been implicated in the repair of DNA damage (Smith et al., 1995; Wang et al., 1995) and genomic instability in primary human breast carcinomas (Eyfj6rd et al., 1995) . Furthermore, we showed previously that epithelial cells derived from human skin or normal human mammary tissue acquired a deficiency in repair of X-ray-induced DNA damage before they could be transformed in culture by chemicals or viruses to malignant cells, as evidenced by their growth as carcinomas in nude mice. These results seem to indate that deficient DNA repair is a prerequisite for carcinogenesis (Gantt et al., 1987; Sanford et al., 1992; Parshad et al., 1994) . Thus, deficient DNA repair, manifest as an abnormally high frequency of chromatid breaks or low activity for incision of UV-induced DNA damag, appears to be a predisposing factor in familial breast cancer. As some women with sporadic breast cancer also have such a deficiency, as shown here and earLer , deficient DNA repair may be a predisposing factor in the development of certain sporadic breast cancers.
